Dr. Verardo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Bronx, NY 10467Phone+1 718-920-4321
Summary
- Angela Verardo, MD, is a Pediatric Endocrinologist based in Bronx, NY, specializing in pediatric bone metabolism disorders and pediatric diabetes endocrinology. She completed her fellowship in Pediatric Endocrinology at Johns Hopkins University after graduating from New York Medical College. Dr. Verardo has held positions as an Assistant Professor at both Montefiore Medical Center and Connecticut Children's Medical Center and has worked extensively at several pediatric medical centers. Her research experience includes publications on pediatric endocrinology and bone metabolism, with multiple clinical trials involving vosoritide and testosterone replacement. Her clinical expertise ranges from precocious puberty to pediatric diabetes. Dr. Verardo is also recognized as a JDRF Walk Healthcare Ambassador.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 2015 - 2018
- NYU Grossman School of MedicineResidency, Pediatrics, 2013 - 2015
- NYU Grossman School of MedicineInternship, Pediatrics, 2012 - 2013
- New York Medical CollegeClass of 2012
Certifications & Licensure
- NJ State Medical License 2020 - 2025
- NY State Medical License 2023 - 2025
- CT State Medical License 2018 - 2020
- MA State Medical License 2019 - 2019
- MD State Medical License 2015 - 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- JDRF Walk Healthcare Ambassador JDRF
Clinical Trials
- Vosoritide for Short Stature in Turner Syndrome Start of enrollment: 2024 Apr 12
- A Phase 2 Study of Vosoritide in Children with Idiopathic Short Stature Start of enrollment: 2024 Oct 21
- Vosoritide for Selected Genetic Causes of Short Stature Start of enrollment: 2020 Aug 04
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsVosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice.Oliver Semler, Valérie Cormier-Daire, Ekkehart Lausch, Michael B Bober, Ricki Carroll
Advances in Therapy. 2024-01-01 - 18 citationsA specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth.Naomi Dirckx, Qian Zhang, Emily Y Chu, Robert J Tower, Zhu Li
Proceedings of the National Academy of Sciences of the United States of America. 2022-11-08 - 5 citationsGenomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblasts.Qian Zhang, Larry D. Mesner, Gina M. Calabrese, Naomi Dirckx, Zhu Li
The Journal of Clinical Investigation. 2021-04-01
Journal Articles
- Genomic variants within chromosome 14q32.32 regulate bone mass through MARK3 signaling in osteoblastsQian Zhang, Larry D Mesner, Gina M Calabrese, Naomi Dirckx, Zhu Li, Angela Verardo, Qian Yang, Robert J Tower, Marie-Claude Faugere, Charles R Farber, Thomas L Clemens, Journal of Clinical Investigation, 4/1/2021
- Osteoblast Bioenergetics and Global Energy Homeostasis.Angela Verardo and Thomas Clemens, Nestle Nutr Inst Workshop Ser.
Press Mentions
- Saint Barnabas Medical Center Welcomes Pediatric Specialty ProvidersMarch 10th, 2021
- Finding Beauty Amidst the TribulationsSeptember 18th, 2019
- Saint Barnabas Medical Center welcomes pediatric specialty providers March 11th, 2021
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: